201 related articles for article (PubMed ID: 12626330)
21. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
[TBL] [Abstract][Full Text] [Related]
22. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.
Ho MM; Ng AV; Lam S; Hung JY
Cancer Res; 2007 May; 67(10):4827-33. PubMed ID: 17510412
[TBL] [Abstract][Full Text] [Related]
23. Kinetic analysis of intracellular Hoechst 33342--DNA interactions by flow cytometry: misinterpretation of side population status?
Smith PJ; Wiltshire M; Chappell SC; Cosentino L; Burns PA; Pors K; Errington RJ
Cytometry A; 2013 Jan; 83(1):161-9. PubMed ID: 23136081
[TBL] [Abstract][Full Text] [Related]
24. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
25. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
[TBL] [Abstract][Full Text] [Related]
26. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
27. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung.
Zhou L; Lim L; Costa RH; Whitsett JA
J Histochem Cytochem; 1996 Oct; 44(10):1183-93. PubMed ID: 8813084
[TBL] [Abstract][Full Text] [Related]
28. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.
Allen JD; Jackson SC; Schinkel AH
Cancer Res; 2002 Apr; 62(8):2294-9. PubMed ID: 11956086
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.
Natarajan K; Xie Y; Nakanishi T; Beck WT; Bauer KS; Ross DD
Biochim Biophys Acta; 2011 Jul; 1809(7):295-305. PubMed ID: 21718815
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone.
Zhou S; Zong Y; Lu T; Sorrentino BP
Biotechniques; 2003 Dec; 35(6):1248-52. PubMed ID: 14682060
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
[TBL] [Abstract][Full Text] [Related]
32. Characterization and localization of side population cells in mouse skin.
Yano S; Ito Y; Fujimoto M; Hamazaki TS; Tamaki K; Okochi H
Stem Cells; 2005; 23(6):834-41. PubMed ID: 15917479
[TBL] [Abstract][Full Text] [Related]
33. EGFR regulates the side population in head and neck squamous cell carcinoma.
Chen JS; Pardo FS; Wang-Rodriguez J; Chu TS; Lopez JP; Aguilera J; Altuna X; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Mar; 116(3):401-6. PubMed ID: 16540898
[TBL] [Abstract][Full Text] [Related]
34. Functional and molecular characterisation of mammary side population cells.
Alvi AJ; Clayton H; Joshi C; Enver T; Ashworth A; Vivanco Md; Dale TC; Smalley MJ
Breast Cancer Res; 2003; 5(1):R1-8. PubMed ID: 12559051
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
36. Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression.
Su C; Picard P; Rathbone MP; Jiang S
J Biol Regul Homeost Agents; 2010; 24(1):19-25. PubMed ID: 20385068
[TBL] [Abstract][Full Text] [Related]
37. ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway.
Liu WH; Liu HB; Gao DK; Ge GQ; Zhang P; Sun SR; Wang HM; Liu SB
Cell Transplant; 2013; 22(10):1859-68. PubMed ID: 23032069
[TBL] [Abstract][Full Text] [Related]
38. ABC transporters as phenotypic markers and functional regulators of stem cells.
Bunting KD
Stem Cells; 2002; 20(1):11-20. PubMed ID: 11796918
[TBL] [Abstract][Full Text] [Related]
39. The phenotypic characters of the stem cells in hepatocytes during liver regeneration: the expression of the Bcrp1/Abcg2 membrane transporter and the Hoechst 33342 export.
Uryvaeva IV; Tsitrin EB; Gorodetsky SI; Tsvetkova IA; Delone GV; Gulyaev DV; Khrushchov NG
Dokl Biol Sci; 2004; 398():413-6. PubMed ID: 15587802
[No Abstract] [Full Text] [Related]
40. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
